Huperzine A
- Generic Name
- Huperzine A
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H18N2O
- CAS Number
- 102518-79-6
- Unique Ingredient Identifier
- 0111871I23
- Background
Huperzine A, is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss Huperzia serrata. The botanical has been used in China for centuries for the treatment of swelling, fever and blood disorders. Recently in clinical trials in China, it has demonstrated neuroprotective effects. It is currently being investigated as a possible tre...
- Indication
Investigated for use/treatment in alzheimer's disease.
- Associated Conditions
- -
- Associated Therapies
- -
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
- Conditions
- Interventions
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Shanghai Mental Health Center
- Target Recruit Count
- 300
- Registration Number
- NCT02931136
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
Effects of Huperzine A in Treatment of Moderate to Severe TBI
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2019-11-05
- Lead Sponsor
- Spaulding Rehabilitation Hospital
- Target Recruit Count
- 14
- Registration Number
- NCT01676311
- Locations
- 🇺🇸
Spaulding Rehabilitation Hospital, Charlestown, Massachusetts, United States
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
- First Posted Date
- 2011-01-25
- Last Posted Date
- 2011-01-25
- Lead Sponsor
- Shandong Luye Pharmaceutical Co., Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT01282619
- Locations
- 🇨🇳
Shanghai Mental Health Center, Shanghai, Shanghai, China
Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
- Conditions
- Interventions
- First Posted Date
- 2010-09-03
- Last Posted Date
- 2017-05-03
- Target Recruit Count
- 84
- Registration Number
- NCT01194336
- Locations
- 🇺🇸
Walter Reed Army Institute of Research, Silver Spring, Maryland, United States
Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A
- First Posted Date
- 2010-06-03
- Last Posted Date
- 2010-06-03
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 8
- Registration Number
- NCT01136551
- Locations
- 🇮🇱
Hadassah University Hospital, Jerusalem, Israel
Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2009-11-13
- Lead Sponsor
- VA Nebraska Western Iowa Health Care System
- Target Recruit Count
- 15
- Registration Number
- NCT01012830
- Locations
- 🇺🇸
Veterans Affairs Nebraska Western Iowa Health Care System, Omaha, Nebraska, United States
Huperzine A in Alzheimer's Disease
- Conditions
- First Posted Date
- 2004-05-27
- Last Posted Date
- 2008-02-21
- Lead Sponsor
- National Institute on Aging (NIA)
- Target Recruit Count
- 150
- Registration Number
- NCT00083590
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸Premiere Research Institute, West Palm Beach, Florida, United States
🇺🇸Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.